John F. Kuckelman

John F. Kuckelman is the legal director at Novo Nordisk, a leading global healthcare company specializing in diabetes care and chronic disease management. He recently made headlines by addressing the company's decision to sue competitor Eli Lilly for allegedly misleading marketing practices concerning their weight loss medications, asserting that pharmaceutical companies have a responsibility to provide accurate and truthful information in their public claims.